![Paul Rowan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Paul Rowan
Sociétés | Poste | Début | Fin |
---|---|---|---|
NoviSci, Inc.
![]() NoviSci, Inc. Data Processing ServicesTechnology Services Part of TARGET PharmaSolutions, Inc., NoviSci, Inc. is a company that uses principled data science to improve population health outcomes for vulnerable patients with complex conditions. The company is based in Durham, NC. The company's novel analytic applications facilitate the efficient deployment of complex research methods from epidemiology and statistics as well as intuitive, interactive visualization of complex results from real-world studies. NoviSci's founders and leaders continue to hold faculty appointments, including at the Duke University School of Medicine and the University of North Carolina at Chapel Hill. The company was founded by Alan M. Brookhart, Paul Rowan, Aaron McKethan. Aaron McKethan has been the CEO since incorporation. NoviSci was acquired by TARGET PharmaSolutions, Inc. on January 15, 2021. | Fondateur | - | - |
Corporate Officer/Principal | - | - |
Historique de carrière de Paul Rowan
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
NoviSci, Inc.
![]() NoviSci, Inc. Data Processing ServicesTechnology Services Part of TARGET PharmaSolutions, Inc., NoviSci, Inc. is a company that uses principled data science to improve population health outcomes for vulnerable patients with complex conditions. The company is based in Durham, NC. The company's novel analytic applications facilitate the efficient deployment of complex research methods from epidemiology and statistics as well as intuitive, interactive visualization of complex results from real-world studies. NoviSci's founders and leaders continue to hold faculty appointments, including at the Duke University School of Medicine and the University of North Carolina at Chapel Hill. The company was founded by Alan M. Brookhart, Paul Rowan, Aaron McKethan. Aaron McKethan has been the CEO since incorporation. NoviSci was acquired by TARGET PharmaSolutions, Inc. on January 15, 2021. | Technology Services |
- Bourse
- Insiders
- Paul Rowan
- Expérience